|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | Oct-2001 | Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19: a novel rearrangement in a patient with myelodysplastic syndrome transforming to acute myeloid leukemia | Forsyth, Cecily J ; Smith, A.; Heaps, L.S.; Sharma, P.; Jarvis, A. |
| 2 | | 30-Dec-2022 | Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count) | Zhang, Lucy ; Campion, Victoria; Dickson, Michelle; Tang, Catherine |
| 3 | | Aug-2012 | All-Trans-Retinoic Acid, Idarubicin, and IV Arsenic Trioxide as initial therapy in Acute Promyelocytic Leukemia (APML4) | Iland, H.J.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Collins, M.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Tiley, Campbell ; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F. |
| 4 | | Jun-2015 | Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies | Tiley, Campbell ; Lynagh, M.C.; Clinton-McHarg, T.; Hall, A.; Sanson-Fisher, R.; Stevenson, W.; Bisquera, A. |
| 5 | | 10-Jan-2024 | Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia | Loh, Zoe; Ashby, Michael; Van Veldhuizen, Ellie; Li, Wenlong; Chee, Ashlyn; Aung, Winpa; Lavrukhina, Yelena; Mason, George; Pelly, Tenille; Nedumannil, Rithin; Kosciejew, Serena; Mokoonlall, Mridula; Lim, Jonathan; Calov, Georgina; Butler, Llewyn; Hillebrand, Paulina; Beekman, Ashley; Rathnasekara, Greasha Kalani; Raj, Sonia; Zhang, Cathey; Yao, Yao ; Iland, Harry; Grigg, Andrew |
| 6 | | 5-Aug-2024 | Asciminib Monotherapy as Frontline Treatment of Chronic-Phase Chronic Myeloid Leukemia: Results from the ASCEND Study | Yeung, David T; Shanmuganathan, Naranie; Reynolds, John; Branford, Susan; Walia, Mannu; Yong, Agnes Sm; Shortt, Jake; Chee, Lynette; Viiala, Nicholas; Cunningham, Ilona; Ross, David M; D'Souza, Alwyn Bernard; Wright, Matthew; Harrup, Rosemary Anne; Forsyth, Cecily ; Filshie, Robin; Lane, Steven W; Browett, Peter J; Grove, Carolyn S; Grigg, Andrew A; Hughes, Timothy P |
| 7 | | Oct-2022 | Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study | Odutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Hertzberg, Mark; Trotman, Judith; Opat, Stephen S; Lindeman, Robert; Roncolato, Fernando; Verner, Emma; Harvey, Michael; Tiley, Campbell ; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 8 | | 30-May-2022 | Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia | Odutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, Henry M; Milliken, Samuel T; Trotman, Judith; Verner, Emma; Tiley, Campbell ; Roncolato, Fernando; Underhill, Craig R; Opat, Stephen S; Harvey, Michael; Hertzberg, Mark; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 9 | | Aug-2021 | Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement | Tiley, Campbell ; Hamad, N.; Ananda-Rajah, M.; Gilroy, N.; MacIntyre, R.; Gottlieb, D.; Ritchie, D.; Harrison, S.; Kennedy, G.; Watson, A.M.; Greenwood, M.; Doocey, R.; Perera, T.; Spencer, A.; Wong, E.; O'Brien, T.; Shaw, P.; Conyers, R.; Milliken, S.; Bardy, P.; Larsen, S.; Ho, P.J.; Lai, H.; Bajel, A.; Butler, J.; D'Rozario, J.; Johnston, A.; Cochrane, T.; Mills, T.; Irving, I.; Pullon, H.; Purtill, D. |
| 10 | | Mar-1996 | Autologous red cell recovery and relapse of multiple myeloma after bone marrow transplantation: is this a graft-versus-myeloma effect? | Forsyth, Cecily J ; Nelson, M.; Popp, H.; Snowdon, L.; Gibson, J.; Joshua, D. |
| 11 | | Jan-2017 | Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea | Forsyth, Cecily J ; Douglas, G.; Harrison, C.N.; Bennett, M.; Stevenson, W.S.; Hounsell, J.; Ratnasingam, S.; Ritchie, D.; Ross, D.M.; Grigg, A. |
| 12 | | 24-Nov-2022 | Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study | Mills, Georgia S; Di Ciaccio, Pietro R; Tang, Catherine ; Chadwick, Verity; Mason, Kylie D; Campbell, Belinda A; Shipton, Michael J; Shanavas, Mohamed; Morris, Kirk L; Greenwood, Matthew; Langfield, Jenna; Kidson-Gerber, Giselle; Eslick, Renee; Badoux, Xavier; Yannakou, Costas K; Gangatharan, Shane A; Bilmon, Ian; Hamad, Nada |
| 13 | | Mar-2017 | A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis | Forsyth, Cecily J ; Ho, P.J.; Bajel, A.; Burbury, K.; Dunlop, L.; Durrant, S.; Perkins, A.C.; Ross, D.M. |
| 14 | | 7-Oct-2022 | Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma | Nath, Christa Ellen; Grigg, Andrew; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell ; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter ; Shaw, Peter John; Trotman, Judith |
| 15 | | Apr-2019 | Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014 | Forsyth, Cecily J ; Baade, P.D.; Ross, D.M.; Anderson, L.A.; Fritschi, L. |
| 16 | | 20-Dec-2022 | Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry | Nguyen, James; Wellard, Cameron; Chung, Eliza; Cheah, Chan Y; Dickinson, Michael; Doo, Nicole Wong; Keane, Colm; Talaulikar, Dipti; Berkahn, Leanne; Morgan, Susan; Hamad, Nada; Cochrane, Tara; Johnston, Anna M; Forsyth, Cecily J ; Opat, Stephen; Barraclough, Allison; Mutsando, Howard; Ratnasingam, Sumita; Giri, Pratyush; Wood, Erica M; McQuilten, Zoe K; Hawkes, Eliza A |
| 17 | | 7-Mar-2023 | The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance | Di Ciaccio, Pietro R; Mills, Georgia; Shipton, Michael J; Campbell, Belinda; Gregory, Gareth; Langfield, Jenna; Greenwood, Matthew; McKeague, Sean; Shanavas, Mohammad; Eslick, Renee; Kidson-Gerber, Giselle; Smallbone, Portia; Tang, Catherine ; Morris, Kirk; Bilmon, Ian; Yannakou, Costas; Badoux, Xavier; Berkahn, Leanne; Farina, Sergio; Mason, Kylie D; Motum, Penelope; Goss, Kathryn; Hamad, Nada |
| 18 | | Feb-2017 | Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory. | Forsyth, Cecily J ; Agarwal, R.; Blombery, P.; McBean, M.; Jones, K.; Fellowes, A.; Doig, K.; Westerman, D.A. |
| 19 | | Dec-2001 | Collection and transport of samples for laboratory testing in von Willebrand's disease (VWD): time for a reappraisal? | Forsyth, Cecily J ; Favaloro, E.J.; Nair, S.C. |
| 20 | | Apr-2008 | Consensus Guidelines for 'Rainy Day' Autologous Stem Cell Harvests in New South Wales | Trotman, J.; Presgrave, Peter ; Kwan, Yiu Lam ; Tiley, Campbell ; Estell, J.; Watson, A.M.; O'Brian, T.A.; Peters, D. |
| 21 | | Aug-2016 | Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort | Forsyth, Cecily J ; Campbell, P.J.; MacLean, C.; Beer, P.A.; Buck, G.; Wheatley, K.; Kiladjian, J.J.; Harrison, C.N.; Green, A.R. |
| 22 | | Apr-2020 | Cutaneous multiple myeloma | Forsyth, Cecily J ; Jagger, Jacqueline ; Lai, S. |
| 23 | | May-2014 | Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea | Forsyth, Cecily J ; Verner, E.; Grigg, A. |
| 24 | | Dec-2018 | The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications | Forsyth, Cecily J ; Melville, K.; Tiley, Campbell |
| 25 | | Jan-2018 | Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thromboses | Forsyth, Cecily J ; Harrison; Balendran, S.; Harrison, A.; Morel-Kopp, M. C.; Ward, C. |
| 26 | | 1994 | Development of a flow cytometric test for the detection of D-positive fetal cells after fetomaternal hemorrhage and a survey of the prevalence in D-negative women | Forsyth, Cecily J ; Nelson, M.; Popp, H.; Horky, K.; Gibson, J. |
| 27 | | 23-Nov-2024 | Diagnosis and management of mantle cell lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance | Barraclough, Allison; Tang, Catherine ; Lasica, Masa; Smyth, Elizabeth; Cirillo, Melita; Mutsando, Howard; Cheah, Chan Y; Ku, Matthew |
| 28 | | Jan-2023 | Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study | Odutola, Michael K; van Leeuwen, Marina T; Bassett, Julie K; Bruinsma, Fiona; Turner, Jennifer; Seymour, John F; Prince, Henry Miles; Milliken, Samuel T; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen S; Lindeman, Robert; Tiley, Campbell ; Trotman, Judith; Verner, Emma; Harvey, Michael; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 29 | | Feb-2012 | Distinguishing types 1 and 2M von Willebrand disease | Forsyth, Cecily J ; Favaloro, E.J.; Koutts, J. |
| 30 | | Apr-2016 | Dysregulation of the intrinsic apoptotic pathway mediates megakaryocytic hyperplasia in myeloproliferative neoplasms | Forsyth, Cecily J ; Malherbe, J.A.; Fuller, K.A.; Mirzai, B.; Kavanagh, S.; So, C.C.; Ip, H.W.; Guo, B.B.; Howman, R.; Erber, W.N. |
| 31 | | Oct-2020 | Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product | Forsyth, Cecily J ; Niederwieser, D.; Hamm, C.; Cobb, P.; Mo, M.; Tucci, A.; Hanes, V.; Delwail, V.; Hajek, R.; Chien, D. |
| 32 | | Feb-2010 | Enrollment of Patients to Clinical Trials in Haematological Cancer in New South Wales: Current Status, Perceived Barriers and Opportunities for Improvement | Murray, P.; Kerridge, Ian ; Tiley, Campbell ; Catanzariti, A.; Welberry, H.; Lean, C.; Sinclair, S.; Bishop, J.; Bradstock, K.F. |
| 33 | | Feb-1995 | First trimester antigen typing of fetal red cells using a flow cytometric technique | Forsyth, Cecily J ; Nelson, M.; Popp, H.; Peat, B.; Boogert, A.; Gibson, J. |
| 34 | | Jan-2019 | Hereditary haemorrhagic telangiectasia | Forsyth, Cecily J ; Mangkorntongsakul, Varitsara |
| 35 | | Jul-2016 | High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; Kwan, Y.L.; Gurney, H.; McLachlan, Andrew ; Earl, J.W.; Nivison-Smith, I.; Zeng, L.; Shaw, P.J. |
| 36 | | Feb-1999 | Hodgkin's disease: a GP's guide to diagnosis and management | Forsyth, Cecily J |
| 37 | | 26-Mar-2024 | How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials? | Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell ; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas J ; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H |
| 38 | | 1991 | How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease | Tiley, Campbell ; Powles, R.; Treleaven, J.; Millar, J.; Gordon-Smith, E.; Findlay, M.; Teo, C.; Duncombe, A.; Robinson, G. |
| 39 | | Jul-2012 | The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease | Forsyth, Cecily J ; Best, O.G.; Che, Y; Singh, N.; Christopherson, R.I.; Mulligan, S.P. |
| 40 | | Dec-1990 | Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial | Tiley, Campbell ; Powles, R.; Smith, C.; Milan, S.; Treleaven, J.; Millar, J.; McElwain, T.; Gordon-Smith, E.; Miliken, S. |
| 41 | | Apr-2018 | Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia | Forsyth, Cecily J ; Crassini, K.R.; Zhang, E.; Balendran, S.; Freeman, J.A.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P. |
| 42 | | Aug-2018 | Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features | Forsyth, Cecily J ; Godfrey, A.L.; Campbell, P.J.; MacLean, C.; Buck, G.; Cook, J.; Temple, J.; Wilkins, B.S.; Wheatley, K.; Nangalia, J.; Grinfeld, J.; McMullin, M.F.; Kiladjian, J.J.; Green, A.R.; Harrison, C.N. |
| 43 | | May-2017 | Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid Leukemia | Tiley, Campbell ; Bradstock, K.F.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.H.; Enno, A.; Schwarer, A.; Lewis, I.D.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.F.; Hahn, U.; Cannell, P.; Lowenthal, R.M.; Moore, J.; Cartwright, K.; Cunningham, I.; Taper, J.; Grigg, A.; Roberts, A.W.; Benson, W.; Hertzberg, M.; Deveridge, S.; Rowlings, P.; Mills, A.K.; Gill, Devinder S ; Bardy, P.; Campbell, L.J.; Seymour, J.F. |
| 44 | | Jun-2023 | Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility | Mills, Georgia S; Chadwick, Verity; Tang, Catherine ; Perram, Jacinta; Anderson, Mary Ann; Anazodo, Antoinette; Kidson-Gerber, Giselle; Shand, Antonia; Lavee, Orly; Withers, Barbara; Milliken, Sam; Di Ciaccio, Pietro R; Hamad, Nada |
| 45 | | Jan-2013 | Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia | Forsyth, Cecily J ; Freeman, J.A.; Crassini, K.R.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P. |
| 46 | | May-2017 | The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia | Forsyth, Cecily J ; Fox, L.; Cummins, K.D.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A. |
| 47 | | May-1997 | Management of acute vascular graft thrombosis associated with HIT syndrome: a case report | Forsyth, Cecily J ; Wilson, M.; McGahan, T.; White, G. |
| 48 | | Sep-2020 | Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Nivison-Smith, I.; Gurney, H.; Zeng, L.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; McLachlan, Andrew ; Shaw, P.J. |
| 49 | | 29-Jun-2022 | Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management | Tang, Catherine ; Shen, Yandong; Soosapilla, Asha; Mulligan, Stephen P |
| 50 | | Dec-2019 | A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons | Tiley, Campbell ; Stevenson, W.; Bryant, J.; Watson, R.; Sanson-Fisher, R.; Oldmeadow, C.; Henskens, F.; Brown, C.; Ramanathan, S.; Enjeti, A.; Guest, J.; Tzelepis, F.; Paul, C.; D'Este, C. |
| 51 | | Aug-2013 | A multicenter, open-label, noncomparative screening study of Enzastaurin in adult patients with Non-Hodgkin Lymphomas | Forsyth, Cecily J ; Gomez-Almaguer, D.; Camargo, J.F.C.; Eliadis, P.E.; Crespo-Solis, E.; Pereira, J.; Gutierrez-Aguirre, C.H.; Rivaz-Vera, S.; Roberson, S.; Lin, B.; Smith, N.V.; Hamid, O. |
| 52 | | Apr-2019 | The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia | Forsyth, Cecily J ; Minson, A.G.; Cummins, K.; Fox, L.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A. |
| 53 | | Oct-2015 | The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway | Forsyth, Cecily J ; Best, O.G.; Singh, N.; Mulligan, S.P. |
| 54 | | Oct-2023 | Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study | Odutola, Michael K; van Leeuwen, Marina T; Bruinsma, Fiona J; Benke, Geza; Turner, Michelle C; Trotman, Judith; Turner, Jennifer; Seymour, John F; Prince, H Miles; Milliken, Samuel T; Tiley, Campbell ; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Verner, Emma; Underhill, Craig R; Cardis, Elisabeth; Giles, Graham; Vajdic, Claire M |
| 55 | | Feb-2015 | The oral iron chelator deferasirox inhibits NF-kappaB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia | Forsyth, Cecily J ; Banerjee, A.; Mifsud, N. A.; Bird, R.; Szer, J.; Tam, C.; Kellner, S.; Grigg, A.; Motum, P.; Bentley, M.; Opat, S.; Grigoriadis, G. |
| 56 | | Oct-1995 | Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men | Forsyth, Cecily J ; Adams, M.R.; Jessup, W.; Robinson, J.; Celermajer, D.S. |
| 57 | | Sep-2019 | Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation | Forsyth, Cecily J ; Joshi, M.; Taper, J.; Rowlings, P.; Campbell, P.; Crispin, P.; Harvey, M.; Underhill, C.; Bayley, A.; Byth, K.; Huang, G.; Hertzberg, M. |
| 58 | | 5-Mar-2023 | Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis | Nagaratnam, Sai ; Harinesan, Nimalan; Wijesinghe, Rajiv; Wong-Doo, Nicole; Lyons, Alison ; Morris, Katrina; Triplett, James |
| 59 | | 14-Jun-2022 | Paraprotein associated heparin resistance during cardiopulmonary bypass | Khuong, Jacqueline N; Forsyth, Cecily J ; Manuel, Lucy; Kingsford-Smith, Kate; Srivastava, Arpit; Bassin, Levi |
| 60 | | Jul-2014 | Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy | Forsyth, Cecily J ; Paidas, M.J.; Quere, I.; Rodger, M. |
| 61 | | Jun-2012 | A Phase II Study of Risk-Adapted Intravenous Melphalan in patients with AL Amyloidosis | Mollee, P.; Tiley, Campbell ; Cunningham, I.; Moore, J.; Prince, M.; Cannell, P.; Gibbons, S.; Tate, J.; Paul, S.; Mar Fan, H.; Gill, Devinder S |
| 62 | | 1-Mar-2024 | Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria | Kulasekararaj, Austin G; Lehtinen, Anna-Elina; Forsyth, Cecily ; Gandhi, Shreyans; Griffin, Morag; Körper, Sixten; Mikala, Gabor; Muus, Petra; Overgaard, Ulrik; Patriquin, Christopher J; Pullon, Humphrey; Shen, Yu-Min; Spearing, Ruth; Szer, Jeff; De la Borderie, Guillemette; Duda, Petra W; Farzaneh-Far, Ramin; Ragunathan, Sharan; Sayegh, Camil E; Vadysirisack, Douangsone D; Schrezenmeier, Hubert |
| 63 | | May-2010 | Population Pharmacokinetics of Melphalan in Patients with Multiple Myeloma Undergoing High Dose Therapy | Nath, C.E.; Shaw, P.J.; Trotman, J.; Zeng, L.; Duffull, S.; Hegarty, G.; McLachlan, Andrew ; Gurney, H.; Kerridge, Ian ; Kwan, Yiu Lam ; Presgrave, P.; Tiley, Campbell ; Joshua, D.; Earl, J.W. |
| 64 | | 13-Oct-2023 | A population-based family case-control study of sun exposure and follicular lymphoma risk | Odutola, Michael K; van Leeuwen, Marina T; Bruinsma, Fiona; Turner, Jennifer; Hertzberg, Mark; Seymour, John F; Prince, H Miles; Trotman, Judith; Verner, Emma; Roncolato, Fernando; Opat, Stephen; Lindeman, Robert; Tiley, Campbell ; Milliken, Samuel T; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 65 | | Aug-2011 | Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants | Forsyth, Cecily J ; Trotman, J.; Fournier, M; Lamy, T.; Seymour, J.F.; Sonet, A.; Janikova, A.; Shpilberg, O.; Gyan, E.; Tilly, H.; Estell, J.; Decaudin, D.; Fabiani, B.; Gabarre, J.; Salles, B.; Van Den Neste, E.; Canioni, D.; Garin, E.; Fulham, M.; Vander Borght, T.; Salles, G. |
| 66 | | Jul-2021 | Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case report | Rogers, James ; Forsyth, Cecily J ; Ford, Tom ; Mikhail, Philopatir |
| 67 | | 1995 | Quantifying the loss of ABO antigenicity in a patient with acute myeloid leukemia by flow cytometric analysis | Forsyth, Cecily J ; Popp, H.J.; Nelson, M.; Falson, M.; Kronenberg, H. |
| 68 | | 1996 | A quick differentiation between iron deficiency and thalassaemia syndrome | Forsyth, Cecily J ; Yuen, S.; Brown, R.; Zarkos, K. |
| 69 | | May-2017 | Raccoon eyes in systemic light chain amyloidosis | Forsyth, Cecily J ; Tiley, Campbell |
| 70 | | Dec-1994 | Rapid detection of Rh(D)- or K-positive fetal red cells in chorion villus samples by a flow cytometric technique | Forsyth, Cecily J ; Nelson, M.; Popp, H.; Gibson, J. |
| 71 | | Sep-1996 | Rapid quantitation of mixed red cell populations using flow cytometry | Forsyth, Cecily J ; Nelson, M.; Popp, H.; Gibson, J. |
| 72 | | Nov-2018 | Recommendations for the use of pegylated interferon-alpha in the treatment of classical myeloproliferative neoplasms | Forsyth, Cecily J ; Chan, Wai-Hoong ; Grigg, A.; Cook, N.C.; Lane, S.W.; Burbury, K.; Perkins, A.C.; Ross, D.M. |
| 73 | | Mar-1995 | Severe hemolysis due to anti-D in a D-negative recipient of an orthotopic liver transplant | Forsyth, Cecily J ; Popp, H.; Kronenberg, H.; McCaughan, G. |
| 74 | | Nov-1992 | Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron | Forsyth, Cecily J ; Coates, A.S.; Childs, A.; Cox, K.; Joshua, D.E.; McNeil, E.; Grygiel, J.J. |
| 75 | | 5-Jul-2023 | Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants | Homan, Claire C; Drazer, Michael W; Yu, Kai; Lawrence, David Michael; Feng, Jinghua; Arriola-Martinez, Luis Alberto; Pozsgai, Matthew J; McNeely, Kelsey E; Ha, Thuong Thi; Venugopal, Parvathy; Arts, Peer; King-Smith, Sarah; Cheah, Jesse Jc; Armstrong, Mark; Wang, Paul; Bödör, Csaba; Cantor, Alan B; Cazzola, Mario; Degelman, Erin S; DiNardo, Courtney D; Duployez, Nicolas; Favier, Rémi; Fröhling, Stefan; Rio-Machin, Ana; Klco, Jeffery M; Krämer, Alwin; Kurokawa, Mineo; Lee, Joanne; Malcovati, Luca; Morgan, Neil V; Georges, Natsoulis; Owen, Carolyn; Patel, Keyur P; Preudhomme, Claude; Raslova, Hana; Rienhoff, Hugh Young; Ripperger, Tim; Schulte, Rachael R; Tawana, Kiran; Velloso, Elvira; Benedict, Yan; Kim, Erika Mijin Kwon; Sood, Raman; Hsu, Amy P; Holland, Steven M; Phillips, Kerry; Poplawski, Nicola; Babic, Milena; Wei, Andrew H; Forsyth, Cecily J ; Mar Fan, Helen; Lewis, Ian; Cooney, Julian P; Susman, Rachel; Fox, Lucy C; Blombery, Piers; Singhal, Deepak; Hiwase, Devendra K; Phipson, Belinda; Schreiber, Andreas W; Hahn, Christopher N; Scott, Hamish S; Liu, Paul P; Godley, Lucy A; Brown, Anna L |
| 76 | | 7-Dec-2023 | Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG | Loo, Sun; Roberts, Andrew W; Anstee, Natasha S; Kennedy, Glen A; He, Simon; Schwarer, Anthony P; Enjeti, Anoop K; D'Rozario, James; Marlton, Paula; Bilmon, Ian A; Taper, John; Cull, Gavin; Tiley, Campbell ; Verner, Emma; Hahn, Uwe; Hiwase, Devendra K; Iland, Harry J; Murphy, Nick; Ramanathan, Sundra; Reynolds, John; Ong, Doen Ming; Tiong, Ing Soo; Wall, Meaghan; Murray, Michael; Rawling, Tristan; Leadbetter, Joanna; Rowley, Leesa; Latimer, Maya; Yuen, Sam; Ting, Stephen B; Fong, Chun Yew; Morris, Kirk; Bajel, Ashish; Seymour, John F; Levis, Mark J; Wei, Andrew H |
| 77 | | Feb-1996 | Thalidomide responsive chronic pulmonary GVHD | Forsyth, Cecily J ; Cremer, P.D.; Torzillo, P.; Iland, H.J.; Young, G.A. |
| 78 | | Jun-1989 | Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model | Tiley, Campbell ; White, L.; Haber, M.; Brian, M.J.; Norris, M.D.; Trickett, A.; Sosula, L.; Stewart, B.W. |
| 79 | | Feb-2015 | TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets. | Yeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.L.; Trotman, J.; Forsyth, Cecily J ; Taper, J.; Ross, D.M.; Beresford, J.; Tam, C.; Mills, A.K.; Grigg, A.; Hughes, T. |
| 80 | | 1995 | Transfusion of patients with haemoglobinopathies | Forsyth, Cecily J ; Chisholm, J.; Popp, H. |
| 81 | | 1991 | Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor | Tiley, Campbell ; Powles, R.; Teo, C.P.; Treleaven, J.; Findlay, M.; Hewetson, M. |
| 82 | | Feb-2020 | Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss | Forsyth, Cecily J ; Venugopal, P.; Gagliardi, L.; Feng, J.; Phillips, K.; Babic, M.; Poplawski, N.K.; Rienhoff, H.Y.,Jr.; Schreiber, A.W.; Hahn, C.N.; Brown, A.L.; Scott, H.S. |
| 83 | | May-2017 | Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study | Forsyth, Cecily J ; Quach, H.; Fernyhough, L.; Henderson, R.; Corbett, G.; Baker, B.; Browett, P.; Blacklock, H.; Underhill, C.; Cannell, P.; Trotman, J.; Neylon, A.; Harrison, S.; Link, E.; Swern, A.; Cowan, L.; Dimopoulos, M.A.; Miles Prince, H. |
| 84 | | Sep-2015 | Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial | Tiley, Campbell ; Iland, H.J.; Collins, M.; Bradstock, K.F.; Supple, S.G.; Catalano, A.; Hertzberg, M.; Browett, P.; Grigg, A.; Firkin, F.; Campbell, L.J.; Hugman, A.; Reynolds, J.; Di Iulio, J.; Taylor, K.; Filshie, R.; Seldon, M.; Taper, J.; Szer, J.; Moore, J.; Bashford, J.; Seymour, J.F. |
| 85 | | 22-Nov-2023 | Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry | Ng, Wei Yang; Erber, Wendy N; Grigg, Andrew; Dunne, Karin; Perkins, Andrew; Forsyth, Cecily ; Ross, David M |
| 86 | | Apr-2012 | When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload? | Forsyth, Cecily J ; Bird, R.; Kenealy, M.; Wellwood, J.; Leahy, M.F.; Seymour, J.F.; To, L.B. |
